Wave Life Sciences (WVE) SEC Filings & 10K Form

$4.66
-0.08 (-1.69%)
(As of 04/26/2024 ET)

Recent Wave Life Sciences SEC Filings

DateFilerForm TypeView
04/05/2024
7:00 PM
Moran Kyle (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:55 AM
Wave Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
6:39 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
9:13 AM
BB BIOTECH AG (Filed by)
Wave Life Sciences (Subject)
Form SC 13G/A
02/07/2024
6:00 PM
Vargeese Chandra (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:05 PM
Moran Kyle (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:10 PM
BOLNO PAUL (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:15 PM
Francis Chris (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
7:03 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Wave Life Sciences (Subject)
Form SC 13G/A
02/06/2024
4:07 PM
GSK plc (Filed by)
Wave Life Sciences (Subject)
Form SC 13G/A
01/17/2024
6:06 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Wave Life Sciences (Issuer)
Form 4/A
01/08/2024
7:11 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:07 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
7:36 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2023
3:33 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
8:26 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
5:06 AM
Wave Life Sciences (Filer)
Form 424B5
12/06/2023
3:13 PM
Wave Life Sciences (Filer)
Form 424B5
11/09/2023
7:52 AM
Wave Life Sciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/09/2023
7:52 AM
Wave Life Sciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/09/2023
6:55 AM
Wave Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2023
6:39 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2023
6:31 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
3:38 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
3:05 PM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2023
8:15 PM
Moran Kyle (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:00 PM
HENRY CHRISTIAN O (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:00 PM
Verdine Gregory L. (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:00 PM
Rawcliffe Adrian (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:00 PM
CORRIGAN MARK (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:00 PM
Wagner Heidi L (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:00 PM
TAKANASHI KEN (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:00 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:00 PM
Tan Aik Na (Reporting)
Wave Life Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
6:56 AM
Wave Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2023
6:37 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
3:01 PM
Wave Life Sciences (Filer)
Form DEF 14A
05/23/2023
6:48 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2023
6:55 AM
Wave Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2023
6:43 AM
Wave Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
4:14 PM
Wave Life Sciences (Filer)
Form 10-K/A
How a $0.25 cent option contract makes my top traders feel (Ad)

If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…

Click now to see for yourself what $0.25 Cent Trades is all about
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:WVE) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners